<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="c21325a9-cd57-4e39-98f2-0727ed8abb2d"><labelDrug name="BiDil"><Normalization><mmtx cui="C0968130" preferredWord="Bidil" semType="phsu, orch"/></Normalization></labelDrug><generic name="Hydralazine hydrochloride and Isosorbide dinitrate"/><sentence id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1" text="BIDIL (hydralazine hydrochloride and isosorbide dinitrate) tablet, film coated" type="negative"><entity charOffset="0:5" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.0" text="bidil" type="Biomedical_Entity"><Normalization><mmtx cui="C0968130" phraseText="BIDIL" preferredWord="Bidil" semType="phsu, orch"/><RxNorm RxCui="303838"/></Normalization></entity><entity charOffset="37:57" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.1" text="isosorbide dinitrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0022252" phraseText="isosorbide dinitrate" preferredWord="Isosorbide Dinitrate" semType="phsu, orch"/><RxNorm RxCui="6057"/></Normalization></entity><entity charOffset="7:32" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.2" text="hydralazine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282198" phraseText="(hydralazine hydrochloride" preferredWord="Hydralazine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.1"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.2"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.2" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.1.e.1"/></sentence><sentence id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2" text="BiDil is a fixed-dose combination of isosorbide dinitrate, a vasodilator with effects on both arteries and veins, and hydralazine hydrochloride, a predominantly arterial vasodilator." type="negative"><entity charOffset="61:72" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.0" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C3537240" phraseText="a vasodilator with effects" preferredWord="Vasodilator [EPC]" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="170:181" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.1" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="a predominantly arterial vasodilator." preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="118:143" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.2" text="hydralazine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282198" phraseText="hydralazine hydrochloride," preferredWord="Hydralazine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><entity charOffset="37:57" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.3" text="isosorbide dinitrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0022252" phraseText="a fixed-dose combination of isosorbide dinitrate," preferredWord="Isosorbide Dinitrate" semType="phsu, orch"/><RxNorm RxCui="6057"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.4" text="bidil" type="Biomedical_Entity"><Normalization><mmtx cui="C0968130" phraseText="BiDil" preferredWord="Bidil" semType="phsu, orch"/><RxNorm RxCui="303838"/></Normalization></entity><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.2"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.3" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.0"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.4" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.0"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.2" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.1"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.3" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.1"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.4" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.1"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.3" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.2"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.4" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.2"/><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.4" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.2.e.3"/></sentence><sentence biomedicalEntities="5" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6" lineNumber="11" text="Augmentation of the vasodilatory effects of isosorbide dinitrate by phosphodiesterase inhibitors such as sildenafil, vardenafil, or tadalafil could result in severe hypotension. " type="regular"><entity charOffset="44:64" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.0" text="isosorbide dinitrate" type="Drug"><Normalization><mmtx cui="C0022252" phraseText="Augmentation of the vasodilatory effects of isosorbide dinitrate" preferredWord="Isosorbide Dinitrate" semType="phsu, orch"/><RxNorm RxCui="6057"/></Normalization></entity><entity charOffset="68:96" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1" text="phosphodiesterase inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0031638" phraseText="by phosphodiesterase inhibitors" preferredWord="Phosphodiesterase Inhibitors" semType="phsu"/><RxNorm RxCui="8228"/></Normalization></entity><entity charOffset="105:115" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.2" text="sildenafil" type="Drug"><Normalization><mmtx cui="C0529793" phraseText="such as sildenafil," preferredWord="sildenafil" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="117:127" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.3" text="vardenafil" type="Drug"><Normalization><mmtx cui="C0971579" phraseText="vardenafil," preferredWord="vardenafil" semType="phsu, orch"/><RxNorm RxCui="1309396"/></Normalization></entity><entity charOffset="132:141" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.4" text="tadalafil" type="Drug"><Normalization><mmtx cui="C1176316" phraseText="tadalafil" preferredWord="tadalafil" semType="phsu, orch"/><RxNorm RxCui="358263"/></Normalization></entity><entity charOffset="158:176" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.8" text="severe hypotension" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.2" drugClass="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1"/><drugClassMembership drug="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.3" drugClass="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1"/><drugClassMembership drug="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.4" drugClass="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1"/><drugInteraction id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.ddi.1"><interaction trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.8"><relations><relation type="hasObject"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.1" trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.6.e.8" type="Specific_Interaction"/></sentence><sentence id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.19" text="Hydralazine hydrochloride can cause tachycardia potentially leading to myocardial ischemia and anginal attacks." type="negative"><entity charOffset="60:67" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.19.e.0" text="leading" type="Biomedical_Entity"><Normalization><mmtx cui="C1442948" phraseText="leading to myocardial ischemia" preferredWord="Plumbum metallicum, homeopathic preparation" semType="inch, phsu"/><RxNorm RxCui="1423667"/></Normalization></entity><entity charOffset="0:25" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.19.e.1" text="hydralazine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282198" phraseText="Hydralazine hydrochloride" preferredWord="Hydralazine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.19.e.1" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.19.e.0"/></sentence><sentence id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.22" text="Pyridoxine should be added to BiDil therapy if such symptoms develop." type="negative"><entity charOffset="0:10" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.22.e.0" text="pyridoxine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034272" phraseText="Pyridoxine" preferredWord="pyridoxine" semType="phsu, orch, vita"/><RxNorm RxCui="684879"/></Normalization></entity><entity charOffset="30:35" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.22.e.1" text="bidil" type="Biomedical_Entity"><Normalization><mmtx cui="C0968130" phraseText="added to BiDil therapy" preferredWord="Bidil" semType="phsu, orch"/><RxNorm RxCui="303838"/></Normalization></entity><pair ddi="false" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.22.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.22.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25" lineNumber="35" text="Due to the hydralazine component of BiDil, monoamine-oxidase inhibitors should be used with caution in patients receiving BiDil." type="regular"><entity charOffset="43:71" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.0" text="monoamine-oxidase inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0026457" phraseText="monoamine-oxidase inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="993349"/></Normalization></entity><entity charOffset="11:22" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.1" text="hydralazine" type="Drug"><Normalization><mmtx cui="C0020223" phraseText="Due to the hydralazine component" preferredWord="Hydralazine" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><entity charOffset="82:99" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.2" text="used with caution" type="Caution_Interaction"/><drugInteraction id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.ddi.1"><interaction trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.1" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.0" trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.25.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26" lineNumber="37" text="Patients treated with BiDil who receive any potent parenteral antihypertensive agent should be continuously observed for several hours for excessive fall in blood pressure." type="regular"><entity charOffset="44:84" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.0" text="potent parenteral antihypertensive agent" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="any potent parenteral antihypertensive agent" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="22:27" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.1" text="BiDil" type="Drug"><Normalization><mmtx cui="C0968130" phraseText="treated with BiDil" preferredWord="Bidil" semType="phsu, orch"/><RxNorm RxCui="303838"/></Normalization></entity><entity charOffset="149:171" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.2" text="fall in blood pressure" type="Specific_Interaction"/><drugInteraction id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.ddi.1"><interaction trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.1" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.0" trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.26.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27" lineNumber="39" text="The effects of BiDil on vasodilators including alcohol may be additive." type="regular"><entity charOffset="15:20" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.0" text="BiDil" type="Drug"><Normalization><mmtx cui="C0968130" phraseText="The effects of BiDil" preferredWord="Bidil" semType="phsu, orch"/><RxNorm RxCui="303838"/></Normalization></entity><entity charOffset="24:36" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.1" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="on vasodilators" preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.2" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="alcohol" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="4:11|62:70" id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.4" text="effects additive" type="Increase_Interaction"/><drugInteraction id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.ddi.1"><interaction trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.4"><relations><relation type="hasObject"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.0" e2="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.1" trigger="Dailymed.c21325a9-cd57-4e39-98f2-0727ed8abb2d.s.27.e.4" type="Increase_Interaction"/></sentence><positiveExamples number="4"/><negativeExamples number="14"/></document>